IPM’s cash, cash equivalents and short-term investments as of Dec. 31, 2016, totaled USD 11.5 million. In 2016, IPM advanced three major programs:

In 2016, IPM received significant support from donors including the Ministry of Foreign Affairs of Denmark, the Flanders Department of Foreign Affairs, the German Federal Ministry of Education and Research, Irish Aid, the Ministry of Foreign Affairs of the Netherlands, Norad, DFID, USAID and the Bill & Melinda Gates Foundation. IPM received approximately USD 29.7 million (cash receipts) in 2016.


IPM’s 2016 financial audits continue a history of full compliance with all financial reporting requirements from all US and international government and private donors. In 2016, IPM again received unqualified, or clean, opinions on all audits in both its South Africa and US offices.


IPM’s Board of Directors, management team and staff are committed to efficiently and effectively deliver on our mission to accelerate the development and availability of prevention products that women can use to protect against HIV infection. Women and girls continue to become infected at alarming rates, especially in sub-Saharan Africa, and new products like the dapivirine ring have the potential to make a significant public health impact. Sustained donor funding for IPM’s activities is essential, and we continue to advocate for increased funds from existing donors and pursue new sources of support to achieve our goals.